Lumos Pharma, Inc. (LUMO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
4200 Marathon Boulevard
Austin, TX 78756
United States of America (the)
Phone
512 215 2630
Website
Sector
Healthcare
Industry
Biotechnology
Employees
30
First IPO Date
November 11, 2011
| Name | Title | Pay | Year Born |
| Richard J. Hawkins | Founder, Chief Executive Officer & Chairman | 854,352 | 1949 |
| Lori D. Lawley | Chief Financial Officer & Principal Accounting Officer | 538,229 | 1984 |
| Bradley J. Powers | Chief Compliance Officer & General Counsel | 677,078 | 1979 |
| John C. McKew | Chief Scientific Officer & President | 860,382 | 1964 |
| Pisit Pitukcheewanont | Chief Medical Officer | 0 | N/A |
| Alpa Parikh | Senior Vice President of CMC & Supply Management | 0 | N/A |
| Aaron Schuchart | Chief Business Officer | 0 | 1966 |
| Lisa Miller | Senior Director of Investor Relations | 0 | N/A |
| Eddie L. Varnado | Corporate Controller | 0 | N/A |
Lumos Pharma, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to advancing and commercializing medical treatments for rare conditions. Their principal therapeutic compound, LUM-201, an orally administered growth hormone secretagogue called ibutamoren, is currently undergoing Phase 2 clinical evaluation. This drug candidate is being investigated for its potential in treating pediatric growth hormone deficiency and various other uncommon endocrine conditions. The company's operations are based in Austin, Texas.